Tabuk Pharmaceutical Manufacturing Company
Tabuk Pharmaceutical Manufacturing Company, commonly referred to as Tabuk Pharma, is a leading player in the pharmaceutical industry, headquartered in Saudi Arabia. Established in 1994, the company has made significant strides in the Middle East and North Africa (MENA) region, focusing on the development, manufacturing, and marketing of high-quality pharmaceutical products. Tabuk Pharma offers a diverse range of core products, including prescription medications, over-the-counter drugs, and specialised formulations, distinguished by their commitment to innovation and quality. The company has achieved notable milestones, positioning itself as a trusted name in healthcare, with a strong market presence and a reputation for excellence in pharmaceutical manufacturing.
DitchCarbon Score
How does Tabuk Pharmaceutical Manufacturing Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Tabuk Pharmaceutical Manufacturing Company's score of 15 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Tabuk Pharmaceutical Manufacturing Company's reported carbon emissions
Tabuk Pharmaceutical Manufacturing Company, headquartered in Saudi Arabia, has made significant commitments towards reducing its carbon emissions, although specific emissions data for the most recent year is currently unavailable. The company is committed to achieving net-zero emissions across all scopes by 2050, with a starting point in 2023. This long-term target aligns with the Science Based Targets initiative (SBTi), reflecting their dedication to sustainable practices within the pharmaceuticals, biotechnology, and life sciences sector. While no absolute emissions figures are provided, Tabuk Pharmaceuticals has demonstrated a proactive approach to climate action by committing to comprehensive emissions reduction strategies. Their commitment to net-zero emissions underscores their responsibility towards mitigating climate change and contributing to a more sustainable future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Tabuk Pharmaceutical Manufacturing Company is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
